-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Acrivon Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2021 to 2024.
- Acrivon Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2025 was -$19.5M, a 14.4% decline year-over-year.
- Acrivon Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$65.7M, a 54% decline from 2023.
- Acrivon Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$42.6M, a 41.6% decline from 2022.
- Acrivon Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$30.1M, a 115% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)